Cargando…
Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma
BACKGROUND: Due to tumor heterogeneity, the diagnosis, treatment, and prognosis of patients with lung squamous cell carcinoma (LUSC) are difficult. DNA methylation is an important regulator of gene expression, which may help the diagnosis and therapy of patients with LUSC. METHODS: In this study, we...
Autores principales: | Li, Xiu-Shen, Nie, Ke-Chao, Zheng, Zhi-Hua, Zhou, Rui-Sheng, Huang, Yu-Sheng, Ye, Zeng-Jie, He, Fan, Tang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825161/ https://www.ncbi.nlm.nih.gov/pubmed/33485313 http://dx.doi.org/10.1186/s12885-021-07807-7 |
Ejemplares similares
-
DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients
por: Wu, Zeng-Hong, et al.
Publicado: (2021) -
DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
por: Xu, Duoduo, et al.
Publicado: (2022) -
Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns
por: Huang, Guichuan, et al.
Publicado: (2021) -
DNA methylation subtypes for ovarian cancer prognosis
por: Yin, Lili, et al.
Publicado: (2021) -
Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
por: Zhang, Pei, et al.
Publicado: (2021)